Flexpoint Ford sells ArtesRx to Linden Capital after scaling it to 16 pharmacies
What's the deal? Flexpoint FordDealroom has a profile for this one. Try Dealroom →, a Chicago-based private equity firm, has sold portfolio company ArtesRxDealroom has a profile for this one. Try Dealroom → to Linden Capital PartnersDealroom has a profile for this one. Try Dealroom →. The transaction marks an exit for Flexpoint, which founded the pharmacy services company in 2023. Terms were not disclosed.
What does ArtesRx do? It acquires, scales, and supports pharmacies serving complex patient populations — including people with serious mental illness, substance use disorders, and intellectual and developmental disabilities. The company operates its pharmacies under local banners to build ties with community members and healthcare providers.
Why now? Under Flexpoint, ArtesRx grew from three pharmacies to 16 across 15 states through organic growth and acquisitions. The firm also expanded its executive team and sales infrastructure, positioning it for a sale.
What they're saying: Michael Fazekas, managing director at Flexpoint Ford, credited chief executive officer Dom Meffe and his team with "redefining pharmacy care for complex patients." Houlihan LokeyDealroom has a profile for this one. Try Dealroom → advised on the transaction.
The bigger picture: Founded in 2005, Flexpoint Ford has invested roughly $9 billion across financial services and adjacent markets. The exit reflects continued private equity interest in specialised pharmacy services for underserved patients.
The signal: The deal points to steady consolidation in pharmacy care aimed at complex patients, an area where local relationships and specialised service models are drawing investor attention.
Read more: third-news.com
Image credit: Generated with Gemini
